Octreotide lowers gastric mucosal blood flow in normal and portal hypertensive stomachs

Surgical Endoscopy and Other Interventional Techniques

Volumn 17, Issue 10, 2003, Pages 1570-1572

  Clarke, D L ^a   McKune, A ^a   Thomson, S R ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Gastric mucosal blood flow; Laser Doppler flowmetry; Octreotide; Splanchnic perfusion

Indexed keywords

OCTREOTIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPY; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; STOMACH MUCOSA BLOOD FLOW;

ADULT; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL AGENTS; HUMANS; HYPERTENSION, PORTAL; LASER-DOPPLER FLOWMETRY; MALE; MONITORING, PHYSIOLOGIC; OCTREOTIDE; REGIONAL BLOOD FLOW; SPLANCHNIC CIRCULATION;

EID: 0344152976     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-002-9274-z     Document Type: Article

References (14)

1. Allen PI, Chesner I, Wheatley K, Goldman M (1988) Human gastric perfusion: evidence for non-uniformity of blood flow. Br J Surg 75: 741-742
2. Bernstein DE, Phillips RS (1998) Portal hypertensive gastropathy. Gastrointest Endosc Clin North Am 14: 697-708
3. Chung RS, Bruch D, Dearlove J (1988) Endoscopic measurement of gastric mucosal blood flow by laser Doppler velocimetry: effect of chronic esophageal variceal sclerosis. Am Surg 54: 116-120
4. Gana TJ, Huhlewych R, Koo J (1987) Focal gastric mucosal blood flow by laser-Doppler and hydrogen gas clearance: a comparative study. J Surg Res 43: 337-343
5. Gana TJ, Soenen GM, Koo J (1990) A controlled study of human resting gastric mucosal blood flow by endoscopic laser-Doppler flowmetry. Gastrointest Endosc 36: 264-267
6. Kvietys PR, Shepherd AP, Granger DN (1985) Laser-Doppler, H2 clearance, and microsphere estimates of mucosal blood flow. Am J Physiol 249: G221-G227
7. Li MK, Sung JJ, Woo KS, et al. (1996) Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: a randomized, double-blind crossover study. Dig Dis Sci 41: 2440-2446
8. Lunde OC, Kvernebo K, Larsen S (1988) Evaluation of endoscopic laser Doppler flowmetry for measurement of human gastric blood flow. Methodologic aspects. Scand J Gastroenterol 23: 1072-1078
9. Panes J, Bordas JM, Pique JM, et al. (1992) Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 103: 1875-1882
10. Panes J, Pique JM, Bordas JM, et al. (1994) Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 20: 336-341
11. Sonnenberg GE, Keller U, Perruchoud A, Burckhardt D, Gyr K (1981) Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 80: 526-532
12. Sonnenberg A, West C (1983) Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut 24: 148-153
13. Sung JJ, Tsui CP, Li MK, Leung FW (1995) Somatostatin attenuates the hyperdynamic circulatory state in the gastric mucosa of rats with portal hypertension. Scand J Gastroenterol 30: 921-926
14. Taranto D, Leonardo G, Beneduce F, et al. (1997) Focal gastric blood perfusion in relation with the endoscopic signs and liver function in cirrhotic patients. Digestion 58: 58-63